JASON LEADER: Open Payments
NPI 1841529591 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 122 payments from 19 companies in 2025. Trend: 2023 $1,329 · 2024 $2,001 · 2025 $2,414
Food & beverage: $2,381Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $405 |
| Janssen Biotech, Inc. | 13 | $269 |
| Madrigal Pharmaceuticals | 17 | $263 |
| Ipsen Biopharmaceuticals, Inc | 13 | $239 |
| Ardelyx, Inc. | 11 | $170 |
| Intercept Pharmaceuticals, Inc. | 7 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $154 |
| Janssen Scientific Affairs, LLC | 1 | $114 |
| Lilly USA, LLC | 5 | $110 |
| Gilead Sciences, Inc. | 4 | $98 |
Products named: TREMFYA, REZDIFFRA, IQIRVO, RINVOQ, IBSRELA, OCALIVA, XIFAXAN, SKYRIZI.
Industry payments across FL — which companies pay providers there.
